Share on LinkedInShare on LinkedIn

ARTICLE · 09 AUGUST 2022

Bolar-Like Hurdle For Generics

Gün + Partners
Gün + Partners
Contributor
Gün + Partners

Gün + Partners

We are one of the oldest and largest law firms in Turkey and are considered internationally to be...

View firm profile
Explore more from Gün + Partners

The judgment of the Ankara IP court in a case involving a marketing authorisation application demonstrates that an exemption similar to the so-called Bolar exemption...

TurkeyIntellectual Property

Precis: The judgment of the Ankara IP court in a case involving a marketing authorisation application demonstrates that an exemption similar to the so-called Bolar exemption can apply to Gx pharmaceutical companies.

Background

The so-called Bolar exemption was introduced into Turkish law on 22 June 2004 with an amendment to Patent Decree Law No 551 and was maintained in the IP Code that entered into force on 10 January 2017.

Article 85/3(c) of the IP Code rules that "experimental acts comprising the invention which is subject to a patent, including the registration of medicines and the relevant tests and experiments" are exempted from patent protection.

On the other hand, existing case law interprets the limits of the so-called Bolar exemption broadly and accepts that, in addition to all kinds of regulatory acts such as price approval and sales permission, applying to the Social Security Institute to be included in their reimbursement list should also be

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from